Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Melatonin (N05Ch01), Excluding Prolonged-Release Tablets With An Effective Strength Of 2Mg As Part Of A So-Called Open-House Model.